𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy of reboxetine in bulimia nervosa after 3 and 6 months of treatment: An open trial

✍ Scribed by L. Garzaro; S. Fassino; A. Pierò; S. Boggio; C. Gramaglia; A. Brustolin; S. Maggiorotto

Book ID
119576508
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
125 KB
Volume
12
Category
Article
ISSN
0924-977X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The efficacy of reboxetine in the treatm
The efficacy of reboxetine in the treatment-refractory patients with panic disorder: an open label study
✍ P. N. Dannon; I. Iancu; L. Grunhaus 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB 👁 2 views

## Abstract ## Background and Objective Selective serotonin reuptake inhibitors (SSRIs) are currently the first‐line treatment for panic disorder, although up to 30% of patients either do not respond to SSRIs or withdraw due to adverse events. Reboxetine, a selective norepinephrine reuptake inhibi

Controlled withdrawal of pramipexole aft
Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome
✍ Claudia Trenkwalder; Karin Stiasny-Kolster; Andreas Kupsch; Wolfgang H. Oertel; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

## Abstract Although dopamine agonists are becoming first‐line therapy for restless legs syndrome (RLS), few reports describe treatment periods exceeding 12 weeks. Here, 150 RLS patients who had responded to pramipexole during a 6‐month run‐in period (mean dose, 0.50 mg) were randomly assigned to r